PAR2- EFFECTS OF A PRIOR AUTHORIZATION POLICY FOR CYCLOOXYGENASE-2 INHIBITORS ON HEALTH-RELATED OUTCOMES IN A MANAGED CARE MEDICAID POPULATION
May 1, 2003, 00:00
10.1016/S1098-3015(10)63904-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)63904-6/fulltext
Title :
PAR2- EFFECTS OF A PRIOR AUTHORIZATION POLICY FOR CYCLOOXYGENASE-2 INHIBITORS ON HEALTH-RELATED OUTCOMES IN A MANAGED CARE MEDICAID POPULATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63904-6&doi=10.1016/S1098-3015(10)63904-6
First page :
Section Title :
Open access? :
No
Section Order :
104